Quantification of bowel motility in gynecological cancer patients during radiotherapy using MRI.

Quantification of bowel motility in gynecological cancer patients during radiotherapy using MRI. - Bowel motility during radiotherapy

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON48630

Enrollment

Registered

2018-05-24

Start date

2018-07-26

Completion date

Unknown

Last updated

2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bowel motility

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * age >18 years * Treatment plan: Definitive radiotherapy with curative intent ± chemotherapy or hyperthermia * Tumor type and stage: - Cervical carcinoma (FIGO IB-IVA). - Vaginal carcinoma (FIGO I-IVA). - Isolated vaginal recurrence of endometrial carcinoma. * Written informed consent

Exclusion criteria

Exclusion criteria: * Claustrophobia * Any 3T MRI contra-indications stated by the AMC MRI safety committee (See protocol appendix A)

Design outcomes

Primary

Measure	Time frame
The primary study parameter of the study is to quantify bowel motility in three orthogonal directions in gynecological cancer patients treated with definitive radiotherapy using MRI.	—

Secondary

Measure	Time frame
The secondary study parameters/endpoints are : - assessment of bowel motility variation within a patient during their treatment course. - assessment of bowel motility variation between patients with a focus on changes of bowel motility associated with major abdominal surgery.	—

Countries

Netherlands

Outcome results